Benefits of dual bronchodilation with QVA149 once daily versus placebo, indacaterol, NVA237 and tiotropium in patients with COPD: The SHINE study

被引：0
|
作者：
Bateman, Eric [1 ]
Ferguson, Gary T. [2 ]
Barnes, Neil [3 ]
Gallagher, Nicola [4 ]
Green, Yulia [4 ]
Horton, Rachael [4 ]
Henley, Michelle [4 ]
Banerji, Donald [5 ]
机构：
[1] Univ Cape Town, Dept Med, Rondebosch, South Africa
[2] Pulm Res Inst Southeast Michigan, Pulm Dept, Livonia, MI USA
[3] Barts Hlth NHS Trust, London Chest Hosp, London, England
[4] Novartis Horsham Res Ctr, Resp Dept, Horsham, W Sussex, England
[5] Novartis Pharmaceut, Resp Dept, E Hanover, NJ USA
来源：
EUROPEAN RESPIRATORY JOURNAL | 2012年 / 40卷
关键词：
COPD; -; management; Bronchodilators;
D O I：
暂无
中图分类号：
R56 [呼吸系及胸部疾病];
学科分类号：
摘要：
7248
引用
收藏
页数：2
相关论文
共 50 条
  • [31] SUPERIOR LUNG FUNCTION WITH ONCE-DAILY QVA149 TRANSLATES INTO IMPROVEMENTS IN PATIENT-REPORTED BREATHLESSNESS COMPARED WITH PLACEBO AND TIOTROPIUM IN COPD PATIENTS: THE BLAZE STUDY
    D'Urzo, A.
    Mahler, D. A.
    Decramer, M.
    Worth, H.
    White, T.
    Alagappan, V. K. T.
    Gallagher, N.
    Chen, H.
    Kulich, K.
    Banerji, D.
    THORAX, 2013, 68 : A184 - A184
  • [32] Dual bronchodilation with QVA149 reduces patient-reported dyspnoea in COPD: the BLAZE study
    Mahler, Donald A.
    Decramer, Marc
    D'Urzo, Anthony
    Worth, Heinrich
    White, Tracy
    Alagappan, Vijay K. T.
    Chen, Hungta
    Gallagher, Nicola
    Kulich, Karoly
    Banerji, Donald
    EUROPEAN RESPIRATORY JOURNAL, 2014, 43 (06) : 1599 - 1609
  • [33] NVA237 ONCE DAILY OFFERS RAPID AND CLINICALLY MEANINGFUL BRONCHODILATION IN COPD PATIENTS THAT IS MAINTAINED FOR 24 H: THE GLOW1 TRIAL
    D'Urzo, T.
    Ferguson, G.
    Martin, C.
    Alagappan, V. K. T.
    Banerji, D.
    Lu, Y.
    Horton, R.
    Overend, T.
    THORAX, 2011, 66 : A170 - A170
  • [34] Bronchodilatory effects of NVA237, a once daily long-acting muscarinic antagonist, in COPD patients
    Fogarty, Charles
    Hattersley, Helen
    Di Scala, Lilla
    Drollmann, Anton
    RESPIRATORY MEDICINE, 2011, 105 (03) : 337 - 342
  • [35] Dual bronchodilation with once-daily QVA149 improves dyspnea and health status and reduces symptoms and rescue medication use in patients with COPD: The IGNITE trials
    Banerji, Donald
    Alagappan, Vijay
    Green, Yulia
    Gallagher, Nicola
    FowlerTaylor, Angel
    D'Andrea, Peter
    Chen, Hungta
    EUROPEAN RESPIRATORY JOURNAL, 2013, 42
  • [36] Dual Bronchodilation With Qva149 Provides A Rapid Onset Of Action Throughout The Course Of Treatment In Patients With COPD
    Dahl, R.
    Gallagher, N.
    Green, Y.
    Bryant, H.
    Chen, H.
    D'Andrea, P.
    Alagappan, V.
    Kho, P.
    Banerji, D.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2013, 187
  • [37] Efficacy And Safety Of Qva149 Versus Glycopyrronium And Tiotropium In Severe To Very Severe COPD: The Spark Study
    Wedzicha, J. A.
    Decramer, M.
    Ficker, J.
    Niewoehner, D. E.
    Sandstrom, T.
    Taylor, A. Fowler
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2013, 187
  • [38] Comparison of COPD Exacerbations With Once-Daily QVA149 Versus Twice-Daily Salmeterol/Fluticasone Combination: The ILLUMINATE Study
    Bateman, Eric
    Vogelmeier, Claus
    Chen, Hungta
    Banerji, Donald
    CHEST, 2014, 145 (03)
  • [39] COMPARISON OF COPD EXACERBATIONS WITH ONCE-DAILY QVA149 VERSUS TWICE-DAILY SALMETEROL/FLUTICASONE COMBINATION: THE ILLUMINATE STUDY
    Vogelmeier, C.
    Bateman, E. D.
    Chen, H.
    Banerji, D.
    THORAX, 2013, 68 : A184 - A185
  • [40] Once-Daily Qva149 Improves Dyspnea, Quality Of Life And Reduces The Rate Of Exacerbations Compared To Tiotropium Plus Formoterol In COPD Patients: The Quantify Study
    Korn, S.
    Gebner, C.
    Schurmann, W.
    Forster, K.
    Sieder, C.
    Hiltl, S.
    Buhl, R.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2014, 189
12345